Clarus Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Clarus Therapeutics's estimated annual revenue is currently $4.2M per year.
- Clarus Therapeutics's estimated revenue per employee is $201,000
Employee Data
- Clarus Therapeutics has 21 Employees.
- Clarus Therapeutics grew their employee count by 0% last year.
Clarus Therapeutics's People
Name | Title | Email/Phone |
---|
Clarus Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15.9M | 79 | 30% | N/A | N/A |
#2 | $91.5M | 455 | 7% | N/A | N/A |
#3 | $26.1M | 130 | 25% | $35M | N/A |
#4 | $15.3M | 76 | -4% | N/A | N/A |
#5 | $6.6M | 33 | -25% | N/A | N/A |
#6 | $5.6M | 28 | -7% | N/A | N/A |
#7 | $4.2M | 21 | -36% | N/A | N/A |
#8 | $10.1M | 50 | -25% | N/A | N/A |
#9 | $225.5M | 1122 | 19% | N/A | N/A |
#10 | $3.2M | 16 | -27% | N/A | N/A |
What Is Clarus Therapeutics?
Clarus Therapeutics, Inc. is a men's specialty pharmaceutical company with a mission to help men with hypogonadism, a condition associated with a deficiency or absence of endogenous testosterone. We are working hard every day to make a difference in the lives of affected men. As a privately-held company, Clarus Therapeutics is backed by Thomas, McNerney & Partners, L.P., H.I.G. BioHealth Partners, ProQuest Investments, C-Bridge Capital Partners, LLC, BVCF Management, Ltd. and Pavilion Capital Pte Ltd. To learn more, visit clarustherapeutics.com. View our community guidelines: http://bit.ly/2H9QmH5
keywords:N/AN/A
Total Funding
21
Number of Employees
$4.2M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Clarus Therapeutics News
NORTHBROOK -- Clarus Therapeutics Holdings, Inc., recently announced that it has received a notice of allowance from the United States...
Clarus Therapeutics Announces Notice of Allowance for Patent Claims Covering JATENZO® (testosterone undecanoate). Published: Apr 28, 2022.
Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.6M | 21 | 0% | N/A |
#2 | $3.1M | 22 | 5% | N/A |
#3 | $3.4M | 23 | -8% | N/A |
#4 | $4.9M | 24 | 14% | N/A |
#5 | $4.4M | 25 | 0% | N/A |